Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM) in a research report report published on Monday morning. The brokerage issued a sell rating on the stock.

Concord Medical Services Price Performance

NYSE:CCM opened at $3.96 on Monday. The company has a current ratio of 0.47, a quick ratio of 0.46 and a debt-to-equity ratio of 1.15. Concord Medical Services has a one year low of $3.80 and a one year high of $26.70. The stock has a 50-day simple moving average of $4.71 and a 200 day simple moving average of $5.41.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.